SAFE (Simple Agreement for Future Equity)
An investment instrument developed by Y Combinator in 2013, providing rights to future equity in exchange for a current capital contribution. SAFEs convert to preferred stock upon a qualified equity financing, acquisition, or dissolution event, typically with a valuation cap, discount, or both. Distinguishable from convertible notes: SAFEs are not debt, do not accrue interest, and have no maturity date. Most-used early-stage investment instrument for U.S. startups.
A SAFE, Simple Agreement for Future Equity, is an investment instrument developed by Y Combinator in 2013, providing rights to future equity in exchange for a current capital contribution. SAFEs convert to preferred stock upon a qualified equity financing, acquisition, or dissolution event, typically with a valuation cap, discount, or both. SAFEs have largely displaced convertible notes as the dominant early-stage investment instrument for U.S. startups, particularly at pre-seed and seed stages, because of their simpler structure and absence of debt features (no interest, no maturity date).
SAFE vs. convertible note
Key distinctions between SAFE and convertible note: (1) SAFE is not debt, no maturity date, no interest accrual, no repayment obligation; (2) convertible note is debt, has maturity date (typically 18-24 months), accrues interest, must be repaid or converted at maturity; (3) SAFE balance sheet treatment, typically equity; (4) convertible note treatment, debt liability until conversion. For founders, SAFEs are typically more favorable: no maturity pressure, no interest accumulation, simpler legal structure. For investors, convertible notes provide more protection: maturity creates leverage, interest provides return on delay.
Conversion mechanics
SAFEs convert to preferred stock upon: (1) qualified equity financing, typically a "Series" round meeting minimum size threshold ($1M+ standard); (2) liquidity event, change of control or IPO; (3) dissolution, winding up of company. Conversion typically uses: (a) valuation cap, maximum conversion price (cap price); (b) discount, discount to the qualified financing price (typically 10-20%); (c) better-of, investor receives the more favorable of cap price or discount price. Some SAFEs include only one mechanism; sophisticated SAFEs include both.
Pre-money vs. post-money SAFE
The two principal SAFE templates: (1) pre-money SAFE, original 2013 template; valuation cap is pre-money valuation; SAFE holders' ownership dilutes when subsequent SAFEs are added; (2) post-money SAFE, Y Combinator's 2018 update; valuation cap is post-money (calculated after all outstanding SAFEs convert); SAFE holders' ownership is fixed and does not dilute from subsequent SAFEs. Post-money SAFE is now the dominant template, it gives investors more certainty about ownership but requires careful cap table management. Most SAFE-issuing startups should be aware which template they're using and the cap table implications.
Standard SAFE terms
Y Combinator's post-money SAFE has four standard variations: (1) cap, no discount, most common; conversion at lower of cap price or financing price; (2) discount, no cap, fixed discount to financing price (e.g., 20%); (3) cap and discount, investor receives more favorable of cap or discount; (4) MFN (most favored nation), investor can elect terms of any subsequent SAFE issued. The four variations support different deal structures; cap-and-discount and cap-only are most common for typical seed deals.
SAFE pitfalls
Common SAFE issues: (1) cap table complexity, multiple SAFEs with different caps, discounts, and conversion mechanics create complexity at conversion; (2) founder dilution surprise, founders sometimes underestimate dilution from outstanding SAFEs at conversion; (3) valuation cap as ceiling, sophisticated investors may push to cap valuation at the cap, even if the round prices higher (typically prevented by careful drafting); (4) side letter complexity, additional terms (information rights, pro rata, MFN) added through side letters; (5) founder antidilution, typically not a feature of standard SAFEs but can be negotiated; (6) tax treatment, SAFE is generally not "stock" for tax purposes (no §83(b) election, no §1202 holding period start), important consideration for founders and investors.
Tax considerations
Tax treatment of SAFEs is uncertain in some respects: (1) investor tax basis, typically the investment amount becomes basis in converted shares; (2) §83(b) election, generally not applicable to SAFEs since they are not stock; investors should make §83(b) on conversion if subject to vesting; (3) §1202 QSBS holding period, typically begins at SAFE conversion, not SAFE issuance, limits early QSBS qualification for SAFE investors; (4) character on conversion, generally non-taxable like a contribution to capital. Sophisticated investors and founders may prefer convertible notes specifically for §1202 timing benefits.
For Texas startups raising early-stage capital, SAFEs are the dominant instrument. Best practice: (1) use Y Combinator post-money SAFE template (most market-standard); (2) maintain comprehensive cap table tracking all outstanding SAFEs and their conversion mechanics; (3) understand cap table impact at conversion under various scenarios, model dilution carefully; (4) coordinate SAFE issuance with Reg D compliance (Form D, accredited investor verification); (5) limit SAFE complexity, multiple cap/discount combinations create management overhead; (6) at qualified financing round, work with counsel to manage SAFE conversion. For investors: (1) understand SAFE is not debt, no maturity, no interest, no repayment if no future round; (2) evaluate cap and discount in context of expected next-round valuation; (3) consider pro rata rights through side letter; (4) recognize tax holding-period implications for §1202 QSBS qualification; (5) document representations regarding accredited status. Common pitfall: founders raising too many SAFEs at increasing caps without modeling cumulative dilution, leading to substantial founder dilution surprise at Series A.